Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation

Tomomi Toubai, Sophie Paczesny, Yusuke Shono, Junji Tanaka, Kathleen P. Lowler, Chelsea T. Malter, Masaharu Kasai, Masahiro Imamura

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Allogeneic hematopoietic cell transplantation (allo-HCT) is an effective therapy for hematological malignancies and inherited diseases. However, acute graft-versus-host-disease (aGVHD) is a major life-threatening complication after allo-HCT and there are few therapeutic options for severe steroid-refractory aGVHD. Preliminary studies on cotransplantation of mesenchymal stem cells (MSCs) have shown an improvement in or resolution of severe aGVHD. However, the underlying mechanism this immunosuppressive effect has not been elucidated. Most of the data suggest that this immunosuppressive effect involves soluble factors such as IL-6 or TGF-β as well as cell-cell contact dependence. MSCs interact either directly with T cells or indirectly via other immune cells such as dendritic cells and NK cells. Here we review the immunomodulatory function of MSCs in allo-HCT and their potential usefulness in the treatment or prevention of severe acute GVHD.

Original languageEnglish (US)
Pages (from-to)252-259
Number of pages8
JournalCurrent Stem Cell Research and Therapy
Volume4
Issue number4
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Cell Transplantation
Graft vs Host Disease
Mesenchymal Stromal Cells
Immunosuppressive Agents
Hematologic Neoplasms
Natural Killer Cells
Dendritic Cells
Interleukin-6
Therapeutics
Steroids
T-Lymphocytes

Keywords

  • Acute graft-versus-host disease (aGVHD)
  • Allogeneic hematopoietic cell transplantation (Allo-HCT)
  • Mesenchymal stem cells (MSCs)
  • Steroid-refractory acute GVHD

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation. / Toubai, Tomomi; Paczesny, Sophie; Shono, Yusuke; Tanaka, Junji; Lowler, Kathleen P.; Malter, Chelsea T.; Kasai, Masaharu; Imamura, Masahiro.

In: Current Stem Cell Research and Therapy, Vol. 4, No. 4, 2009, p. 252-259.

Research output: Contribution to journalArticle

Toubai, Tomomi ; Paczesny, Sophie ; Shono, Yusuke ; Tanaka, Junji ; Lowler, Kathleen P. ; Malter, Chelsea T. ; Kasai, Masaharu ; Imamura, Masahiro. / Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation. In: Current Stem Cell Research and Therapy. 2009 ; Vol. 4, No. 4. pp. 252-259.
@article{f17478e3bd684a3ba24aa23a83a43253,
title = "Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation",
abstract = "Allogeneic hematopoietic cell transplantation (allo-HCT) is an effective therapy for hematological malignancies and inherited diseases. However, acute graft-versus-host-disease (aGVHD) is a major life-threatening complication after allo-HCT and there are few therapeutic options for severe steroid-refractory aGVHD. Preliminary studies on cotransplantation of mesenchymal stem cells (MSCs) have shown an improvement in or resolution of severe aGVHD. However, the underlying mechanism this immunosuppressive effect has not been elucidated. Most of the data suggest that this immunosuppressive effect involves soluble factors such as IL-6 or TGF-β as well as cell-cell contact dependence. MSCs interact either directly with T cells or indirectly via other immune cells such as dendritic cells and NK cells. Here we review the immunomodulatory function of MSCs in allo-HCT and their potential usefulness in the treatment or prevention of severe acute GVHD.",
keywords = "Acute graft-versus-host disease (aGVHD), Allogeneic hematopoietic cell transplantation (Allo-HCT), Mesenchymal stem cells (MSCs), Steroid-refractory acute GVHD",
author = "Tomomi Toubai and Sophie Paczesny and Yusuke Shono and Junji Tanaka and Lowler, {Kathleen P.} and Malter, {Chelsea T.} and Masaharu Kasai and Masahiro Imamura",
year = "2009",
doi = "10.2174/157488809789649269",
language = "English (US)",
volume = "4",
pages = "252--259",
journal = "Current Stem Cell Research and Therapy",
issn = "1574-888X",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation

AU - Toubai, Tomomi

AU - Paczesny, Sophie

AU - Shono, Yusuke

AU - Tanaka, Junji

AU - Lowler, Kathleen P.

AU - Malter, Chelsea T.

AU - Kasai, Masaharu

AU - Imamura, Masahiro

PY - 2009

Y1 - 2009

N2 - Allogeneic hematopoietic cell transplantation (allo-HCT) is an effective therapy for hematological malignancies and inherited diseases. However, acute graft-versus-host-disease (aGVHD) is a major life-threatening complication after allo-HCT and there are few therapeutic options for severe steroid-refractory aGVHD. Preliminary studies on cotransplantation of mesenchymal stem cells (MSCs) have shown an improvement in or resolution of severe aGVHD. However, the underlying mechanism this immunosuppressive effect has not been elucidated. Most of the data suggest that this immunosuppressive effect involves soluble factors such as IL-6 or TGF-β as well as cell-cell contact dependence. MSCs interact either directly with T cells or indirectly via other immune cells such as dendritic cells and NK cells. Here we review the immunomodulatory function of MSCs in allo-HCT and their potential usefulness in the treatment or prevention of severe acute GVHD.

AB - Allogeneic hematopoietic cell transplantation (allo-HCT) is an effective therapy for hematological malignancies and inherited diseases. However, acute graft-versus-host-disease (aGVHD) is a major life-threatening complication after allo-HCT and there are few therapeutic options for severe steroid-refractory aGVHD. Preliminary studies on cotransplantation of mesenchymal stem cells (MSCs) have shown an improvement in or resolution of severe aGVHD. However, the underlying mechanism this immunosuppressive effect has not been elucidated. Most of the data suggest that this immunosuppressive effect involves soluble factors such as IL-6 or TGF-β as well as cell-cell contact dependence. MSCs interact either directly with T cells or indirectly via other immune cells such as dendritic cells and NK cells. Here we review the immunomodulatory function of MSCs in allo-HCT and their potential usefulness in the treatment or prevention of severe acute GVHD.

KW - Acute graft-versus-host disease (aGVHD)

KW - Allogeneic hematopoietic cell transplantation (Allo-HCT)

KW - Mesenchymal stem cells (MSCs)

KW - Steroid-refractory acute GVHD

UR - http://www.scopus.com/inward/record.url?scp=74849103341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74849103341&partnerID=8YFLogxK

U2 - 10.2174/157488809789649269

DO - 10.2174/157488809789649269

M3 - Article

C2 - 19500066

AN - SCOPUS:74849103341

VL - 4

SP - 252

EP - 259

JO - Current Stem Cell Research and Therapy

JF - Current Stem Cell Research and Therapy

SN - 1574-888X

IS - 4

ER -